Tristel Full Year 2024 Earnings: Revenues Beat Expectations

Tristel (LON:TSTL) Full Year 2024 Results

Key Financial Results

• Revenue: UK£41.9m (up 17% from FY 2023).
• Net income: UK£6.49m (up 46% from FY 2023).
• Profit margin: 16% (up from 12% in FY 2023). The increase in margin was driven by higher revenue.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Tristel Revenues Beat Expectations

Revenue exceeded analyst estimates by 1.1%.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

The company's shares are up 6.2% from a week ago.

Valuation

If you are seeking undervalued stocks, our analysis of 6 valuation measures indicates Tristel could be a good place to look. You can access our in-depth analysis and discover what the outlook is like for the stock by clicking here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.